|
1
|
Attwa MH and El-Etreby SA: Guide for
diagnosis and treatment of hepatocellular carcinoma. World J
Hepatol. 7:1632–1651. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhou CC, Yang F, Yuan SX, Ma JZ, Liu F,
Yuan JH, Bi FR, Lin KY, Yin JH, Cao GW, et al: Systemic genome
screening identifies the outcome associated focal loss of long
noncoding RNA PRAL in hepatocellular carcinoma. Hepatology.
63:850–863. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Okajima W, Komatsu S, Ichikawa D, Miyamae
M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H,
et al: Liquid biopsy in patients with hepatocellular carcinoma:
Circulating tumor cells and cell-free nucleic acids. World J
Gastroenterol. 23:5650–5668. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bunch H: Gene regulation of mammalian long
non-coding RNA. Mol Genet Genomics. 293:1–15. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng
JH: lncRNA MALAT1 promotes proliferation and metastasis in
epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med
Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI
|
|
8
|
Xia H, Liu Y, Wang Z, Zhang W, Qi M, Qi B
and Jiang X: Long noncoding RNA HOTAIRM1 maintains tumorigenicity
of glioblastoma stem-like cells through regulation of HOX gene
expression. Neurotherapeutics. 17:754–764. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li G, Shi H, Wang X, Wang B, Qu Q, Geng H
and Sun H: Identification of diagnostic long noncoding RNA
biomarkers in patients with hepatocellular carcinoma. Mol Med Rep.
20:1121–1130. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN,
Zhang JY, Liu C and Qu K: Six-long non-coding RNA signature
predicts recurrence-free survival in hepatocellular carcinoma.
World J Gastroenterol. 25:220–232. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jeong G, Bae H, Jeong D, Ham J, Park S,
Kim HW, Kang HS and Kim SJ: A Kelch domain-containing KLHDC7B and a
long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer
cell proliferation via the interferon signaling pathway. Sci Rep.
8(12922)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fang K, Hu C, Zhang X, Hou Y, Gao D, Guo Z
and Li L: lncRNA ST8SIA6-AS1 promotes proliferation, migration and
invasion in breast cancer through the p38 MAPK signalling pathway.
Carcinogenesis. 41:1273–1281. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Luo ML, Li J, Shen L, Chu J, Guo Q, Liang
G, Wu W, Chen J, Chen R and Song E: The role of APAL/ST8SIA6-AS1
lncRNA in PLK1 activation and mitotic catastrophe of tumor cells. J
Natl Cancer Inst. 112:356–368. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Huang CM, Cao GY, Yang CX, Chen Y, Liu GD,
Xu BW and Zhang X: lncRNA ST8SIA6-AS1 promotes colorectal cancer
cell proliferation, migration and invasion by regulating the
miR-5195/PCBP2 axis. Eur Rev Med Pharmacol Sci. 24:4203–4211.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
He C, Liu Z, Jin L, Zhang F, Peng X, Xiao
Y, Wang X, Lyu Q and Cai X: lncRNA TUG1-Mediated Mir-142-3p
downregulation contributes to metastasis and the
epithelial-to-mesenchymal transition of hepatocellular carcinoma by
targeting ZEB1. Cell Physiol Biochem. 48:1928–1941. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fu Y, Sun LQ, Huang Y, Quan J, Hu X, Tang
D, Kang R, Li N and Fan XG: miR-142-3p inhibits the metastasis of
hepatocellular carcinoma cells by regulating HMGB1 gene expression.
Curr Mol Med. 18:135–141. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang X, Xu S, Hu C, Fang K, Zhou J, Guo
Z, Zhu G and Li L: lncRNA ST8SIA6-AS1 promotes hepatocellular
carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
Biochem Biophys Res Commun. 533:1039–1047. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li Y and Jiang A: ST8SIA6-AS1 promotes
hepatocellular carcinoma by absorbing miR-5195-3p to regulate
HOXB6. Cancer Biol Ther. 21:647–655. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20(5758)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Long J, Bai Y, Yang X, Lin J, Yang X, Wang
D, He L, Zheng Y and Zhao H: Construction and comprehensive
analysis of a ceRNA network to reveal potential prognostic
biomarkers for hepatocellular carcinoma. Cancer Cell Int.
19(90)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18(28)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang J, Cai M, Jiang D and Xu L:
Upregulated lncRNA-CCAT1 promotes hepatocellular carcinoma
progression by functioning as miR-30c-2-3p sponge. Cell Biochem
Funct. 37:84–92. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Jin C, Xiao L, Zhou Z, Zhu Y, Tian G and
Ren S: miR-142-3p suppresses the proliferation, migration and
invasion through inhibition of NR2F6 in lung adenocarcinoma. Hum
Cell. 32:437–446. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xu T, He BS, Pan B, Pan YQ, Sun HL, Liu
XX, Xu XN, Chen XX, Zeng KX, Xu M and Wang SK: miR-142-3p functions
as a tumor suppressor by targeting RAC1/PAK1 pathway in breast
cancer. J Cell Physiol. 235:4928–4940. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hua S, Liu C, Liu L and Wu D: miR-142-3p
inhibits aerobic glycolysis and cell proliferation in
hepatocellular carcinoma via targeting LDHA. Biochem Biophys Res
Commun. 496:947–954. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yu Q, Xiang L, Chen Z, Liu X, Ou H, Zhou J
and Yang D: MALAT1 functions as a competing endogenous RNA to
regulate SMAD5 expression by acting as a sponge for miR-142-3p in
hepatocellular carcinoma. Cell Biosci. 9(39)2019.PubMed/NCBI View Article : Google Scholar
|
